other
confidence high
sentiment neutral
materiality 0.10
Avenue Therapeutics sets Dec 30, 2025 annual meeting; Nov 28 deadline for proposals
AVENUE THERAPEUTICS, INC.
- Annual meeting scheduled for December 30, 2025; proxy statement to be filed with SEC.
- Shareholder proposals for proxy inclusion under Rule 14a-8 must be received by November 28, 2025.
- Director nominations and other non-14a-8 proposals also due by November 28, 2025.
- All proposals must be submitted in writing to Corporate Secretary at Bay Harbor Islands address.